FDA Inspection
Labcorp Drug DevelopmentLabcorp Drug Development – FDA Inspection, Apr 25, 2022
Record Details
This FDA Inspection record concerns Labcorp Drug Development, with an inspection on April 25, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Labcorp Drug Development
- Inspection Date
- April 25, 2022
- Product Type
- Drugs
View Company Profile
ID · a50d857a-14b9-4f79-ab98-34070136da78
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1168630
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Labcorp Drug Development
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 17, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 5, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 19, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 26, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 13, 2012 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Labcorp Drug Development
- FDA Inspection 1147393 - 2021-06-17
- FDA Inspection 1123056 - 2020-03-05
- FDA Inspection 1064469 - 2018-07-19
- FDA Inspection 1022660 - 2017-07-26
- FDA Inspection 790402 - 2012-07-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.